Editor’s Note: This article is the second in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. (Click here to read part 1.) The series is based.
The Federal Trade Commission announced Monday that it had reversed its in-house Administrative Law Judge s Initial Decision dismissing a complaint brought by FTC staff against Illumina, Inc. s. | April 20, 2023
Federal Trade Commission reversed in-house Administrative Law Judge Initial Decision dismissing complaint brought by FTC staff against Illumina’s acquisition of GRAIL. FTC found acquisition violated Clayton Act Section 7, ordered Illumina, who will likely appeal, to divest.
The Federal Trade Commission (“FTC”) announced Monday that it had reversed its in-house Administrative Law Judge’s (“ALJ”) Initial Decision dismissing a complaint brought by FTC staff.